-
Jul 162025Batch Production of 4-Nitrophenylsulfur Pentafluoride
There are few companies in the market that offer 4-Nitrophenylsulfur pentafluoride, and those that do can only produce small quantities in laboratory
-
Jul 152025Increasing Catalyst Recovery Rate – We Reduced Product Costs
Catalysts are widely used in chemical production processes, and their high cost undoubtedly significantly increases the costs and selling prices of ch
-
Jul 142025Custom Production of Niraparib Intermediate Successfully Completed
A client entrusted our company to produce an intermediate of niraparib, with our production covering the entire process from raw materials. This produ
-
Jun 112025Custom Pyridine Intermediates: Cutting Costs Through Innovation
Our company specializes in custom-producing pyridine intermediates, managing the entire process from raw material sourcing to final production. Histor
-
Jun 112025Delivery of small quantities of dangerous goods by sea
The transportation of small quantities of dangerous goods has always been a headache, and Conier helps customers solve this problem!
-
Dec 292025Upstream raw materials and downstream products of Benzene
Petroleum benzene is generally produced through processes such as catalytic reforming, ethylene cracking, and toluene disproportionation, with high pu
-
Dec 252025Introduction to the application of peptides and their drugs in the field
The relationship between peptides and biomedicine is extremely close, and it is one of the core components of modern biomedicine. Simply put, peptides
-
Dec 0120258 innovative drugs expected to receive FDA approval on December
New drugs that may be approved by the US FDA in December Active ingredient: Lerodalcibep Indications: primary hyperlipidemia, atherosclerotic cardiova
-
Aug 192025Novo Nordisk: Smeaglutide approved for the treatment of MASH in the United St...
Semalutide was approved by FDA for the first time since 2021 to be applicable to adult patients with an initial body mass index (BMI) of 30 kg/m2 or h
-
Aug 042025FDA approves presbyopia eye drops
LENZ Therapeutics announced today that the US FDA has approved Vizz (Aceclidine ophthalmic solution) 1.44% for the treatment of adult patients with pr
-
Aug 012025The results of the Phase 3 trial of Rinvoq (upadacitinib) have been announced
AbbVie announced today that its JAK inhibitor Rinvoq (upadacitinib) has reached the primary endpoint in a critical study of the Phase 3 UP-AA clinical
-
Jul 282025Top 10 Clinical Trials Worth Paying Attention
Industry media BioPharma Dive recently released a special report, selecting 10 potential clinical trials from numerous ongoing projects that are expec

